Where does Idenix Pharmaceuticals LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Idenix Pharmaceuticals LLC ranks #8,407 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Idenix Pharmaceuticals LLC hold?

Idenix Pharmaceuticals LLC holds 38 US utility patents granted between 2015 and 2021, spanning 14 technology areas.

What is Idenix Pharmaceuticals LLC's Innovation Score?

Idenix Pharmaceuticals LLC has an Innovation Score of 40.9 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Idenix Pharmaceuticals LLC's patent grant rate increasing or decreasing?

Idenix Pharmaceuticals LLC's recent grant velocity is -59% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Idenix Pharmaceuticals LLC's patents?

Idenix Pharmaceuticals LLC's patents average 25.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Idenix Pharmaceuticals LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Idenix Pharmaceuticals LLC

Q: What technology areas does Idenix Pharmaceuticals LLC focus on?

Idenix Pharmaceuticals LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 35 patents. Grants appear in 14 CPC subclasses total.

USPTO PatentsView assignee record - 38 granted patents across 14 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Idenix ranks #8,407 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 14 technology areas.

#8,407
of 49,997 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 25.6
avg claims per patent: -59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8407 · US Corporation #8,407 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,407/49,997
PHOTO-FINISH Ikanos Communications
CPC-FOCUS A61P · 14 areas
INNOV-PAR 40.9/100
CLAIMS-DENSE 25.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ikanos Communications, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
GEA Process… · near

41
Gogo · near

41
Idenix Pharmaceuticals · this assignee

41
Karl Leibinger… · near

41
OPower · near

41
3D Lighting… · lowest

7

What this shows Idenix's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Idenix's grants concentrate

Idenix Pharmaceuticals LLC is a focused PatentsView assignee: 14 CPC subclasses with 92.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (9 grants) versus a trough of 3 in 2018. By volume, Idenix sits between Indium Corporation and Invoy Holdings Inc..

Indium

38
Innowireless

38
Ipla Holdings

38
Iridex

38
Ikanos Communicat…

38
Intelmate

38
Intermetro Indust…

38
Invoy Holdings

38
Idenix Pharmaceut… ◀

38

What this shows Idenix holds 38 patents at rank #8,411, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Idenix

By rank, the assignees closest to #8,411 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Idenix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Idenix, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Karl Leibinger Medizintechnik GMBH & Co. KG 41 OPower, Inc. 41 GEA Process Engineering A/S 41 Gogo LLC 41

Idenix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Idenix Pharmaceuticals LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	23.7%
2016	7	18.4%
2018	3	7.9%
2019	8	21.1%
2020	8	21.1%
2021	3	7.9%

Which technologies does Idenix Pharmaceuticals LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 35

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 32

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 27

C07D - Heterocyclic Compounds 10

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 8

Y02A - Technologies FOR Adaptation TO Climate Change 3

C07K - Peptides 2

G03C - Photosensitive Materials FOR Photographic Purposes ; Photographic Processes, e.g. Cine, X-ray, Colour, Stereo-photographic PROCESSES; Auxiliary Processes IN Photography 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C07C - Acyclic OR Carbocyclic Compounds 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#8,407

of 49,997 tracked assignees

Innovation Score

40.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Idenix Pharmaceuticals LLC's patent record in context - here's where to go next.

Idenix Pharmaceuticals LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 92.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,407 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Idenix Pharmaceuticals LLC against Indium Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.